The MFDS announced that it is in the process of applying for a preliminary review of the combination drug Mifepristone(generic for Mifegyne) and Misoprostol.

The MFDS has also initiated a guideline for safe use of abortion pill and is also planning to collect opinions from experts such as gynecologists and women's groups.

On the 24th, the MFDS made this announcement in a written inquiry by Nam In-soon, a member of Democratic Party of Korea and the National Assembly's Health and Welfare Committee. She inquired about the current status of domestic screening along with the efficacy and safety of Mifegyne in use in 74 countries around the world. The MFDS replied that it is being used after i